Our university starts development of new bio drugs based on global R&D cooperation
- Views 731
- Writer 커뮤니케이션팀
- 보도일자 2015-04-20
Director of the Industry-Academic Cooperation Foundation of our university, Lee Eui-yong, visited NTU on Monday, April 6, where he closed an agreement to pursue an international joint research project for new drug development with Research Department President Ram Kin Yong.
According to the contract, the SIS Immunity Studies Research Center (Director Cho Dae-ho) of our university, NTU, and Samsung Seoul Hospital will participate in the project and jointly fund the budget. Director Cho Dae-ho explained the background to the partnership, "There is very little technological developments in the bio drugs area domestically, and we have to depend on import for almost all bio drugs and related materials. Thus, we decided to pursue an international joint research project for development of the bio industry, which is a core field for a creative economy."
The SIS Immunity Studies Research Center has secured candidate substances for the new bio drug, and has been recognized for its source technology by being selected for a bio new drug development R&D project by the Pan-Ministries New Drug Development Business last year. NTU recently established a Nanyang Institute Technology in Health and Medicine (NITHM) that combines the Colleges of Medicine and Engineering, and is focusing on commercial technology development such as a smart drug relaying system. Samsung Seoul Hospital will aid clinical tests of the results. Director Cho said, "We expect the joint research of Sookmyung Women's University, which has secured candidate substances and source technology, and NTU, which has strengths of technology commercialization and upgrades, will lead to a maximized synergy effect."
The bio drugs market takes up 20 percent of the around 1 trillion dollar pharmaceuticals market (2013), and is a promising industry where average annual growth of 9.9 percent is expected. Our university plans to secure strategic technology in the field and create a bridgehead for global market advancement through this global R&D cooperation project. Head of the Industry-Academic Cooperation Foundation, Lee Eui-yong, revealed, "We will secure a technological cooperation network through this joint research and development with a global partner, and make efforts to provide a future vision for our country through activation of the bio drugs industry and creation of new jobs."